HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy.
Salman S, Meyers DJ, Wicks EE, Lee SN, Datan E, Thomas AM, Anders NM, Hwang Y, Lyu Y, Yang Y, Jackson W 3rd, Dordai D, Rudek MA, Semenza GL.
Salman S, et al. Among authors: wicks ee.
J Clin Invest. 2022 May 2;132(9):e156774. doi: 10.1172/JCI156774.
J Clin Invest. 2022.
PMID: 35499076
Free PMC article.